Corporate governance overhang haunts Sun Pharma despite management rebuttal

Corporate governance overhang haunts Sun Pharma despite management rebuttal

Corporate governance overhang haunts Sun Pharma despite management rebuttal Sun Pharma has been trying to restore investor confidence, after a scathing note by Australian brokerage firm Macquarie and a whistleblower complaint to the Securities and Exchange of India (SEBI) last week, the drug maker stock since then dropped one-fifth of its value.